Cargando…

Association of galactose and insulin resistance in polycystic ovary syndrome: A case-control study

BACKGROUND: Polycystic ovary syndrome (PCOS) is closely linked to metabolic disorders. Recent reports have identified galactose as having strong associations with metabolic disorders, however, the correlation between galactose and PCOS remains largely unknown. METHODS: The serum galactose levels of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Na, Zhijing, Jiang, Hongyu, Meng, Yaxin, Song, Jiahui, Feng, Di, Fang, Yuanyuan, Shi, Bei, Li, Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035629/ https://www.ncbi.nlm.nih.gov/pubmed/35480079 http://dx.doi.org/10.1016/j.eclinm.2022.101379

Ejemplares similares

Elevated Serum Leptin Levels as a Predictive Marker for Polycystic Ovary Syndrome
por: Peng, Yuanyuan, et al.
Publicado: (2022)

Identification of novel candidate biomarkers and immune infiltration in polycystic ovary syndrome
por: Na, Zhijing, et al.
Publicado: (2022)

Insulin resistance and fertility in polycystic ovary syndrome.
por: Fica, S, et al.
Publicado: (2008)

Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome
por: Li, Li, et al.
Publicado: (2020)

New markers of insulin resistance in polycystic ovary syndrome
por: Polak, K., et al.
Publicado: (2016)

Limitations of insulin resistance assessment in polycystic ovary syndrome
por: Lewandowski, Krzysztof C, et al.
Publicado: (2018)

Is Insulin Resistance an Intrinsic Defect in Asian Polycystic Ovary Syndrome?
por: Lee, Hyejin, et al.
Publicado: (2013)

Markers of insulin resistance in Polycystic ovary syndrome women: An update
por: Amisi, Chantal Anifa
Publicado: (2022)

Association between polycystic ovarian morphology and insulin resistance in women with polycystic ovary syndrome
por: Lee, Jeong Eun, et al.
Publicado: (2023)

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome
por: Hwang, Kyu Ri, et al.
Publicado: (2013)

Retinol-Binding Protein 4 and Insulin Resistance in Polycystic Ovary Syndrome
por: Hutchison, Samantha K., et al.
Publicado: (2008)

Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship?
por: Enzevaei, Anahita, et al.
Publicado: (2014)

Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
por: Rojas, Joselyn, et al.
Publicado: (2014)

The relation of dermcidin with insulin resistance and inflammation in women with polycystic ovary syndrome
por: Akan, Ozden Yildirim, et al.
Publicado: (2022)

Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance
por: Genazzani, Alessandro D, et al.
Publicado: (2023)

Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
por: Wanderley, Miriam da Silva, et al.
Publicado: (2018)

Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance
por: Lin, Lin, et al.
Publicado: (2015)

Type A insulin resistance syndrome misdiagnosed as polycystic ovary syndrome: a case report
por: Lin, Lu, et al.
Publicado: (2019)

World Congress on the Insulin Resistance Syndrome, 2009: Insulin resistance mechanisms, the brain, and insulin resistance in youth and in the polycystic ovary syndrome
por: Bloomgarden, Zachary T.
Publicado: (2010)

Differential expression of microRNA in the serum of patients with polycystic ovary syndrome with insulin resistance
por: Huo, Yan, et al.
Publicado: (2022)

A network pharmacology study of mechanism and efficacy of Jiawei Huanglian-Wendan decoction in polycystic ovary syndrome with insulin resistance
por: Shi, Na, et al.
Publicado: (2022)

Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
por: Seeber, Beata, et al.
Publicado: (2014)

Elevated Serum Mannose Levels as a Marker of Polycystic Ovary Syndrome
por: Feng, Di, et al.
Publicado: (2019)

Diamel Therapy in Polycystic Ovary Syndrome Reduces Hyperinsulinaemia, Insulin Resistance, and Hyperandrogenaemia
por: Hernández-Yero, Arturo, et al.
Publicado: (2012)

Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary Syndrome
por: Xiang, Shou-Kui, et al.
Publicado: (2012)

Recurrent Pregnancy Loss in Polycystic Ovary Syndrome: Role of Hyperhomocysteinemia and Insulin Resistance
por: Chakraborty, Pratip, et al.
Publicado: (2013)

Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome
por: Hamilton, Kristen P, et al.
Publicado: (2019)

Associations of Serum Magnesium With Insulin Resistance and Testosterone in Women With Polycystic Ovary Syndrome
por: Luo, Xi, et al.
Publicado: (2021)

Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome?
por: Sahin, Murat, et al.
Publicado: (2016)

Lower Fiber Consumption in Women with Polycystic Ovary Syndrome: A Meta-Analysis of Observational Studies
por: Leung, Wing Ting, et al.
Publicado: (2022)

Effects of Moringa oleifera on Insulin Levels and Folliculogenesis in Polycystic Ovary Syndrome Model with Insulin Resistance
por: Amelia, Dessy, et al.
Publicado: (2018)

Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review
por: He, Fang-fang, et al.
Publicado: (2020)

Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome
por: Zhang, Haolin, et al.
Publicado: (2023)

Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome
por: Kyaw Tun, Tommy, et al.
Publicado: (2016)

Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome
por: Lai, Yerui, et al.
Publicado: (2016)

Optimal Cutoff Points for Anthropometric Variables to Predict Insulin Resistance in Polycystic Ovary Syndrome
por: Hatami, Hossein, et al.
Publicado: (2017)

Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
por: Al-Jefout, Moamar, et al.
Publicado: (2017)

Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome
por: Qu, Qinglan, et al.
Publicado: (2017)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_er3p3g3dbr7lu4h7lrutgu835i